Interventional device developer Boston Scientific of Natick, MA, has released financial results for its 2004 fiscal first quarter (end-March 31).
For the period, the firm had net sales of $1.082 billion, up 34% compared with $807 million reported for the first quarter of 2002. The firm said that, excluding the favorable impact of $58 million in foreign currency fluctuations, net sales were $1.024 billion, an increase of 27%.
Net income for the quarter rose to $194 million, a 100% increase compared with $97 million in the same period last year. The company noted that net income for the prior year included net special charges of $20 million.
By AuntMinnie.com staff writersApril 20, 2004
Related Reading
Boston Scientific ups stake in Aspect, April 9, 2004
Boston Scientific launches Sentinol, April 8, 2004
FDA approves Boston Scientific fibroids treatment, March 30, 2004
Boston Scientific, EndoTex complete enrollment, March 25, 2004
Boston Scientific gets FDA approval for Taxus, March 5, 2004
Copyright © 2004 AuntMinnie.com
